EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Recipient‐Donor Sex Constellation in Liver Transplantation for Hepatocellular Carcinoma—An ELTR Study

Christian Tibor Josef Magyar iD, Noah Free Arteaga, Giacomo Germani iD, Vincent Hassan Karam iD, Rene Adam iD, Renato Romagnoli iD, Paolo De Simone iD, Fabien Robin iD, Daniel Cherqui iD, Andrea Boscà iD, Vincenzo Mazzaferro iD, Yiliam Fundora iD und 17 weitere

Liver International · 2025

DOI: 10.1111/liv.16178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Christian Tibor Josef Magyar und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Transplantation, Liver Neoplasms, Registries. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Hepatocellular carcinoma (HCC) is the third leading cause of cancer‐related death worldwide. Liver transplantation (LT) is a curative treatment option. We investigated survival outcomes based on recipient‐donor sex constellation (RDSC) following LT.

Methods

We performed a European Liver Transplant Registry analysis, including patients from 1988 to December 2022. The cohort was split into four RDSC groups: female donor female recipient (FDFR), female donor male recipient (FDMR), male donor female recipient (MDFR) and male donor male recipient (MDMR). Survival analysis, including death with recurrence, was performed.

Results

In 7601 LT for HCC with an overall median follow‐up of 22.6 months (5.8, 60.7), death was registered in 25.1% and, as primary cause of death, HCC tumour recurrence in 26.0%. There was no statistically significant difference on crude survival estimates among the different RDSC groups (log‐rank p = 0.66) with 10‐year overall survival (OS) of 54.5% in FDFR, 54.6% in FDMR, 59.1% in MDFR and 56.9% in MDMR. On multivariable analysis, RDSC showed a significant effect on OS (FDFR as reference): MDFR (aHR 0.72, p = 0.023). No significant difference was found for FDMR (aHR 0.98, p = 0.821) and MDMR (aHR 0.90, p = 0.288). Regarding overall registered causes of death, differences between RDSC groups were found in rejection ( p = 0.017) and cardiovascular ( p = 0.046) associated deaths.

Conclusions

In female recipients undergoing LT for HCC, male donor grafts were associated with a 28% reduction of mortality compared to female donor grafts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver TransplantationLiver NeoplasmsRegistriesHumansMaleFemaleMiddle AgedSex FactorsEuropeNeoplasm Recurrence, LocalAdultTissue DonorsSurvival AnalysisAgedTransplant RecipientsRetrospective Studies

Stichwörter der Autor:innen

hepatocellularliver transplantationmortalitypatient/donor sexprognosis

Autor:innen und Institutionen

  • Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.
  • The European Society for Organ Transplantation, Amsterdam, Netherlands.
  • Department of Surgery, AP-HP Hôpital Paul Brousse, Université Paris-Saclay, Villejuif, France.
  • General Surgery 2U-Liver Transplant Unit, AOU Città della Salute della Scienza di Torino, University of Turin, Turin, Italy.
  • Hepatobiliary Surgery and Liver Transplantation, University of Pisa Medical School Hospital, Pisa, Italy.

ORCID-Profile: Christian Tibor Josef Magyar, Giacomo Germani, Vincent Hassan Karam, Rene Adam, Renato Romagnoli, Paolo De Simone, Fabien Robin, Daniel Cherqui, Andrea Boscà, Vincenzo Mazzaferro, Yiliam Fundora, Michael Heneghan, Laura Llado, Mickael Lesurtel, Matteo Cescon, Darius Mirza, Corina Kim-Fuchs, Anja Lachenmayer, Guido Beldi, Daniel Candinas, Iuliana-Pompilia Radu, Annalisa Berzigotti, Vanessa Banz

Zitieren

APA

Magyar, C. T. J., Arteaga, N. F., Germani, G., Karam, V. H., Adam, R., Romagnoli, R., De Simone, P., Robin, F., Cherqui, D., Boscà, A., Mazzaferro, V., Fundora, Y., Heneghan, M., Llado, L., Lesurtel, M., Cescon, M., Mirza, D., Cavelti, A., Christen, L., …, & European Liver and Intestine Transplant Association (ELITA) (2025). Recipient‐Donor Sex Constellation in Liver Transplantation for Hepatocellular Carcinoma—An ELTR Study. Liver International. https://doi.org/10.1111/liv.16178

Vancouver

Magyar CTJ, Arteaga NF, Germani G, Karam VH, Adam R, Romagnoli R, et al. Recipient‐Donor Sex Constellation in Liver Transplantation for Hepatocellular Carcinoma—An ELTR Study. Liver International. 2025. doi:10.1111/liv.16178

BibTeX
@article{Magyar2025,
  author = {Magyar, Christian Tibor Josef and Arteaga, Noah Free and Germani, Giacomo and Karam, Vincent Hassan and Adam, Rene and Romagnoli, Renato and De Simone, Paolo and Robin, Fabien and Cherqui, Daniel and Boscà, Andrea and Mazzaferro, Vincenzo and Fundora, Yiliam and Heneghan, Michael and Llado, Laura and Lesurtel, Mickael and Cescon, Matteo and Mirza, Darius and Cavelti, Andrea and Christen, Lucienne and Storni, Federico and Kim-Fuchs, Corina and Lachenmayer, Anja and Beldi, Guido and Candinas, Daniel and Radu, Iuliana-Pompilia and Schwacha-Eipper, Birgit and Berzigotti, Annalisa and Banz, Vanessa and European Liver and Intestine Transplant Association (ELITA), European Liver and Intestine Transplant Association (ELITA)},
  title = {Recipient‐Donor Sex Constellation in Liver Transplantation for Hepatocellular Carcinoma—An ELTR Study},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.16178}
}
Kostenlos starten →